Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group.

Infants with cardiopulmonary disease develop severe illness from respiratory syncytial virus (RSV) infection. Safety, feasibility, and pharmacokinetics of intravenous gamma globulin (IVIG) to prevent RSV illness were studied in 23 high-risk infants in a phase I trial. IVIG with an RSV neutralizing a...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Groothuis, J R, Levin, M J, Rodriguez, W, Hall, C B, Long, C E, Kim, H W, Lauer, B A, Hemming, V G
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 1991
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC245192/
https://ncbi.nlm.nih.gov/pubmed/1718213
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items